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To the Editor: Rift Valley fever
(RVF) is an undifferentiated febrile
illness caused by Rift Valley fever
virus (RVFV). Several human out-
breaks occurred in Africa, resulting in
tens of thousands of infections (1,2).
During fall 2000, an outbreak of RVF
in the Arabian Peninsula (the first
recorded outside of Africa) resulted in
many human and animal fatalities
(3,4). Severe and frequently fatal
encephalitis thought to be directly
related to viral invasion of the central
nervous system develops in <1% of
patients (5). Encephalitis complicat-
ing RVF is poorly described in the lit-
erature, which offers no detailed
description of the clinical findings,
results of cerebrospinal fluid (CSF)
studies, or imaging. We describe a
case of RVF encephalitis associated
with retinitis, including CSF findings,
viral culture results, and neuroradiolo-
gy findings
An 18-year-old woman from Jazan
(southwest of Saudi Arabia) had a 3-
day history of confusion, fever, and
blurred vision at the time an RVF out-
break was peaking in Jazan.
Philadelphia-chromosome–positive
chronic myeloid leukemia (CML) had
been diagnosed in her several months
before (leukocyte count 108 x 109/L).
She responded well to hydroxyurea,
and she had been in stable-phase
CML for a few months. At the time of
her visit, her temperature was 39.2°C,
blood pressure 110/70 mm Hg, pulse
120 beats/min, respiratory rate
22/min. She had no lymphadenopa-
thy, pallor, or jaundice. Results of her
head, neck, and throat examinations
were normal. Her chest was clear, and
her abdomen was soft and nontender.
Her spleen was 3 cm below the left
costal margin. She was conscious and
oriented. No meningeal signs could be
elicited. Pupils were equally reactive
to light with normal extraocular
movements. Extremities had normal
tone, power, sensation, and reflexes.
Plantar reflex was flexor bilaterally.
She had ataxic gait and bilateral reti-
nal hemorrhages. She was unable to
count fingers. Hemoglobin was 100
g/L, leukocyte count 5.1 x 109/L, and
platelets 373 x 109/L. Renal and liver
function tests were normal. Contrast-
enhanced computed tomography (CT)
scan of the brain was normal. Urine
analysis and malaria smear were neg-
ative. CSF was clear. CSF glucose
was 3.9 mmol/L (serum 5.8), protein
455 mg/L. CSF leukocyte count was
323 x 106/L, 58% lymphocytes, and
38% polynuclearleukocytes. Tests for
hepatitis B surface antigen, antibodies
to hepatitis C virus, HIV, cytomega-
lovirus antigenemia, rheumatoid fac-
tor, and antinuclear antibodies were
negative. Cultures from blood, CSF,
and urine were negative for bacteria.
CSF viral culture was negative.
Polymerase chain reaction for herpes
simplex virus and enterovirus from
CSF was negative. Tests for serum
anti-RVF virus immunoglobulin M
were positive. No other tests for
RVFV were performed. Bone marrow
on admission day was consistent with
CML in remission. Prednisone was
started on admission for 7 days.
On hospital day 5, the patient was
noted to be agitated, confused, and
unresponsive to commands. She was
transferred to the intensive care unit
after her level of consciousness
decreased; she was moving all four
limbs but did not respond to verbal
commands or painful stimuli. Pupils
were 5 mm equal bilaterally with a
sluggish reaction to light. Corneal
reflexes were reactive bilaterally. Gag
reflex was present, and tone was
increased in all four limbs with brisk
reflexes and extensor planter respons-
es. The next day, her condition deteri-
orated, and she became unresponsive
to painful stimuli. Repeated CT scan
of the brain showed no pathologic
changes. Electroencephalogram
showed generalized continuous rhyth-
mic sharp and spike wave activity
consistent with nonconvulsive status
epilepticus. Magnetic resonance
imaging (MRI) of the brain showed
bilateral frontoparietal high signal
intensity on T2-weighted images and
evidence of subtle right posterior thal-
amic hyperintensity with no corre-
sponding abnormalities in T1-weight-
ed images. The axial diffusion MRI
images were more elaborative, show-
ing multiple bilateral asymmetrical
cortical hyperintense areas consistent
with an ischemic or inflammatory
process. Phenytoin was started. The
next day, the patient was able to open
her eyes and responded to painful
stimuli, corneal reflexes were present
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bilaterally, oculocephalic reflex was
present, and planters were flexors
bilaterally. Repeat CSF studies on day
30 showed glucose of 3.8 mmol/L,
protein 431 mg/L, leukocyte count of
12 x 106/L, and 68% polynuclear-
leukocytes. Repeat CT scan of the
brain showed new bilateral temporo-
occipital hypodensity more on the left
side and a probable right middle cere-
bellar and left thalamic internal cap-
sule infarct. There was no intracranial
hemorrhage or hydrocephalus. She
was discharged home awake, blind,
quadreparetic, and incontinent, on
anticonvulsants. After 1 year, her neu-
rologic condition had not changed.
Encephalitis and retinitis are
severe complications of RVF, devel-
oping 1 or 2 weeks into the course of
diseases. By that time, RVFV antigen
assay is negative. Our patient met the
definition of an RVF case during the
outbreak (3). In one outbreak in
Mauritania, 4.9% of observed infec-
tions had encephalitis (6), although
the true frequency of encephalitis in
RVF may be overestimated because
infection can go unrecognized. The
literature contains limited clinical
description of this syndrome (6–8).
Detailed neuroimaging findings,
including MRI and flow studies, have
not been previously reported. These
findings, along with the patient’s clin-
ical signs and symptoms, suggest
cerebral vasculitis; however, no
angiogram was performed, and mark-
ers of vasculitis were negative. A
more likely cause would be direct
viral parenchymal invasion.
The pathogenesis of RVF
encephalitis in humans is not clear.
Animal studies indicate that active
viral replication and necrotizing
encephalitis with diffuse perivascular
infiltrates of lymphocytes and
macrophages occur in cerebral
parenchyma (9,10). Postmortem
histopathologic examination of brains
of fatally infected rhesus monkeys
have shown a mild, nonsuppurative,
multifocal, perivascular encephalitis
in the cerebral cortex, primarily of
lymphoplasmacytic cells and nodular
aggregates of neutrophils in associa-
tion with mild necrotic changes of
neurons (11). In one patient who died
of meningoencephalitis in South
Africa, brain pathologic findings
showed perivascular cuffing and
round-cell infiltration (2). In humans,
we are not aware of positive RVFV
cultures from CSF, blood, or brain
during encephalitis. We have no rea-
son to suspect CML to influence dis-
ease manifestations in this patient.
CML was in stable phase for several
months and should not have affected
immune response of the patient
towards RVFV.
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